Clinilabs opens phase I unit in New Jersey

Tuesday, May 29, 2012

New York-based Clinilabs, an early phase and specialty CRO, has opened a second phase I unit in southern New Jersey. The 50-bed capacity, 15,000-square-foot Specialty Pharma Phase I Unit features semi-private rooms, a large PK sampling facility, a bioanalytic laboratory, pharmacy and exam rooms.

[Read More]

Clinilabs chosen for COPD trial

Wednesday, April 27, 2011

CRO Clinilabs, a company that provides early-stage and clinical drug development services, has been selected to conduct a phase I clinical research study of an investigational medication in patients with chronic obstructive pulmonary disease (COPD).

[Read More]

Clinilabs Names Greenberg Director of Expanded Unit

Wednesday, November 26, 2008

New York, NY-based contract research organization (CRO) Clinilabs appointed Howard Greenberg, M.D., senior medical director of the company’s newly expanded clinical pharmacology unit. Greenberg has served as the principal investigator or co-investigator for more than 100 clinical trials and co-authored more than 30 peer-reviewed research publications. Most recently, he was group medical director at Bristol-Meyers Squibb.

[Read More]